BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Positive Clinical Evidence For AxoGen, Inc.'s Avance® Nerve Graft Continues To Build

  February 6, 2014

   · 

  6 min read
• Miraculins Inc. Release: Diabetes In China: Canadian Biotech Aims To Make A Difference

  February 6, 2014

   · 

  1 min read
• BioCapital

  All Physicians In Switzerland Are Now Able To Prescribe Sucampo Pharmaceuticals, Inc.'s AMITIZA® For Chronic Idiopathic Constipation

  February 6, 2014

   · 

  1 min read
• Business

  Tauriga Sciences Inc. Executes Five Year Service Agreement With The University of Cincinnati Research Institute

  February 6, 2014

   · 

  1 min read
• Drug Development

  Zealand Pharma Informs That Sanofi (France) Has Announced Initiation Of The Lixilan Phase 3 Clinical Program For The Fixed-Ratio Combination Of Lantus® And Lyxumia®

  February 6, 2014

   · 

  1 min read
• Policy

  FDA Grants Acceptance To File And Priority Review For TopoTarget A/S’s Beleodaq™ (Belinostat) NDA In PTCL

  February 6, 2014

   · 

  1 min read
• Business

  NuVasive, Inc. Announces Strategic Executive Leadership Changes

  February 6, 2014

   · 

  4 min read
• Business

  LDR Holding Corporation Announces Fourth Quarter 2013 Conference Call

  February 6, 2014

   · 

  1 min read
• Pharm Country

  Celsus Therapeutics Announces The Closing Of $9.2 Million Public Offering And Full Exercise Of Underwriter’s Option To Purchase Additional Adss

  February 6, 2014

   · 

  1 min read
• Biotech Bay

  AntriaBio To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On Tuesday, February 11, 2014

  February 6, 2014

   · 

  3 min read